UnitedHealth beat by 30% and named Anthropic as its AI partner. TSMC added another $100 billion in US investment. SpaceX faces a 911.5 million share lockup release in early August.
Chips fell again today. TSMC posted record earnings and still dropped. Positioning has gotten that extreme.
The real action was elsewhere. The largest US health insurer just had its best quarter in years and named an AI partner nobody expected.
Two oil supply shocks are now running at the same time. And the clock on the biggest lockup release in IPO history just got one day shorter.
PMD LENS
UnitedHealth named Anthropic the same day Anthropic is meeting IPO investors. Implementation services, not model shipping, just became the documented revenue framework at Fortune 10 scale. Anthropic's Ode venture, backed by Blackstone and Goldman, now has its first named customer at $1.5 billion in committed AI spend.
Google Pays Apple $20 Billion a Year to Stay the Default Search Engine on iPhones.
Most people think it's about search. It's not. It's about data.
Google collects 20X more of it than Apple — fueling an ad revenue engine that generates $250 billion annually. In the AI era, that data is more valuable than ever.
That's why investors are watching Mode Mobile.
While Big Tech profits from your clicks, searches, and behavior — Mode built a platform that lets users participate in the value they create. Its EarnOS platform rewards everyday smartphone activity and has already reached:
- 490M+ users
- $115M+ lifetime revenue
- $1B+ earned and saved by users
As AI makes user data increasingly valuable, Mode's opportunity keeps growing — and they've already locked in their Nasdaq ticker $MODE.
Pre-IPO shares are still available at just $0.52, with up to 20% bonus shares.
Disclaimer: Please read the offering circular and related risks at invest.modemobile.com. This is a paid advertisement for Mode Mobile’s Regulation A+ Offering. Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur. The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.
- UnitedHealth (UNH) still faces DOJ investigations over Medicare billing.
- Ode has 100 engineers and plans to be a trillion-dollar company.
- Russian diesel exports collapsed to near zero from 800K barrels daily.
- South Korea just banned new single-stock leveraged ETF listings.
UnitedHealth Reset Guidance. Anthropic Is the Named AI Partner.
UnitedHealth (UNH) posted a Q2 beat its own CFO called "almost like doing a reset on guidance." Earnings came in well above expectations. Revenue beat. Net income rose sharply from a year ago. Full-year guidance was raised substantially above analyst estimates. Shares jumped in premarket.
The medical cost ratio is what actually drove it. Q2 came in nearly three percentage points lower than a year ago and well below what Wall Street was modeling. Better plan design, higher premiums, and tighter cost management all contributed. AI was named as a specific tool for identifying unusual patterns in medical claims.
Then came the unexpected part. UnitedHealth announced a formal partnership with Anthropic. The company is committing $1.5 billion to AI this year to speed up prior authorizations and detect billing fraud. The CFO was explicit: AI is not deciding whether care is approved or denied.
The partnership runs through Ode, a joint venture Anthropic launched in May with Blackstone, Goldman Sachs (GS), and Hellman & Friedman. Ode has 100 engineers, operates on a Claude-first principle, and competes with Deloitte and Accenture for implementation work. Private equity firms backing it will channel their portfolio companies to the venture as customers.
UnitedHealth is still under DOJ investigation over Medicare billing. The CFO offered no update. AI-driven margin recovery at the same company the DOJ is examining is a genuinely uncomfortable combination.
The Signal to Watch
Cigna (CI), Elevance (ELV), or Humana (HUM) naming an Anthropic partnership before Q3 earnings confirms this is the start of an insurer vertical, not a one-off deal.
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert
Luke Lango was ranked America's #1 stock picker in 2020. He was mentored by two hedge fund billionaires from the Soros network and trained at Caltech. His readers have had the chance to see gains as high as AMD +8,500%... Nvidia +5,000%... Tesla +3,500%... Palantir +1,000%... and Apple +890%. Now he's releasing his next big pick.
This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.
SIGNAL 1: TSMC Added $100 Billion in US Investment. The Stock Fell Anyway.
Taiwan Semiconductor Manufacturing (TSM) announced an additional $100 billion in Arizona chip plants, taking its total US commitment to $265 billion. The company posted its fifth consecutive quarter of record earnings. Revenue grew sharply. Profit jumped more. Full-year revenue growth guidance moved from above 30% to above 40%.
The stock fell. Investors appear to be unwinding chip positions regardless of earnings quality. Dell Technologies (DELL) also dropped on AI overbuild fears. South Korea banned new leveraged ETF listings tied to chip stocks after extreme market swings.
TSMC's $265 billion is the physical infrastructure behind every AI model being trained. The fact that record earnings no longer lift the stock means positioning drove the trade more than fundamentals ever did.
The Signal to Watch
A second Asian foundry announcing a US commitment above $50 billion before Q4 earnings means the migration is industry-wide.
SIGNAL 2: SpaceX Faces 911.5 Million Shares Releasing in Early August.
SpaceX (SPCX) closed Wednesday just above its $135 IPO price after touching $132 intraday. Shares are down roughly a third from their post-IPO record. The company is valued at nearly 49 times expected revenue. Tesla (TSLA) trades at 15 times.
The mechanics problem is straightforward. SpaceX's IPO made less than 5% of shares available for trading. In early August, employees and early investors can sell 911.5 million shares on the second trading day after the first quarterly earnings report. Those shares are worth roughly $123 billion at current prices, more than the $86 billion already on Nasdaq.
Anthropic is planning an October IPO. Institutional buyers pricing Anthropic will have just watched how SpaceX handled this release. SpaceX is now the most recent reference point in the room.
The Signal to Watch
SpaceX holding above $135 through the August lockup release is the single most important data point for Anthropic's October pricing.
SIGNAL 3: Oil Has Two Supply Shocks Running. Russia Is the Second.
J.P. Morgan identified Russian refinery constraints compounding Hormuz. Russian refinery runs fell sharply and are roughly 2 million barrels per day below last year. Russian diesel exports have collapsed to near zero from almost 800,000 barrels per day in 2025.
Global inventories excluding China have fallen to record lows. US distillate margins have surged toward record highs. J.P. Morgan expects WTI to average around $81 in Q3. US senators are advancing a bill that would impose 100% tariffs on the top buyers of Russian oil and gas including China and India.
Hormuz gets the headlines. Russian refinery collapse is adding to the same tightening underneath.
The Signal to Watch
Senate passage of the Russian sanctions bill before Q3 earnings adds a tariff layer on top of the existing supply shortage.
WARNING: A Major Market Shift Could Hit Stocks in 2026
If you have any money in the stock market, you may want to pay attention.
New research points to a massive market-moving event that could send hundreds of popular stocks into a sudden free fall.
Holding the wrong stocks when this hits could erase years of gains.
That’s why analysts have now identified a list of stocks investors may want to avoid as this event unfolds.
If you want to see what’s coming — and which stocks could be most at risk —
Cigna, Elevance, or Humana naming Anthropic before Q3 earnings confirms UnitedHealth opened a vertical. SpaceX above $135 through August tells you whether the AI IPO buyer pool is intact for October. A second Asian foundry US fab commitment above $50 billion confirms TSMC's migration is not a solo move. Senate passage of the Russian sanctions bill converts a two-shock oil market into three layers.
UnitedHealth reset guidance on a 30% beat with a named Anthropic partnership at $1.5 billion. TSMC hit $265 billion in US commitment and fell 2.3%. SpaceX (SPCX) faces 911.5 million shares releasing in early August at $135.27.
The question underneath every healthcare insurer position: does the thesis hold if Anthropic becomes the AI partner for the whole vertical? Cigna (CI), Humana (HUM), and Elevance (ELV) are the three names to watch. One announcement confirms it. Three confirms it is not reversible.
UnitedHealth named Anthropic as its Fortune 10 AI partner. TSMC committed $265 billion in US fabs and fell. SpaceX faces its first lockup release below IPO price. Russian refinery collapse is compounding Hormuz.
A second insurer naming Anthropic, SpaceX above $135 through August, and Senate passage of the Russian sanctions bill are the three signals that define whether the Anthropic implementation framework goes vertical, whether the AI IPO buyer pool survives the lockup, and whether the oil supply picture gets a third layer before July 28.
